Back to Awarded Treatment Trials
Awarded Trial: 02T-160
Grant ID
02T-160
Illness
Bipolar Disorder
Primary Drug/Intervention
Methylphenidate
Primary Dosage
20mg/d - 60mg/d
Secondary Drug Intervention
Atomoxetine
Secondary Dosage
Twice-daily dosing of 1.2 mg/kg/day
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Schweitzer
Sample Size
30
Duration of Study Period for Each Subject
19 weeks
Outcome Measurements
KIDDIE-SADS, YMRS, CGIS, Children's Global Assessment Scale, Conner?s Parent & Teacher Rating Scale, Childhood Depression Rating Scale-Revised
Results
Poor enrollment resulted in termination of this grant.
Publication
N/A
Link
N/A
PI Name
Julie Schweitzer
Degree
PhD
Center
University of Maryland School of Medicine
Institution
MPRC, White Building
Address
P.O. Box 21247
City or Town
Catonsville
State or Province
MD
Zip or Postal Code
21247
Country
USA
Email Address
jschweit@mprc.umaryland.edu